Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation
30. Dezember 2021 18:14 ET
|
Leonhardt Ventures LLC
Mission Viejo, California, United States, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC announced today filing of a patent application covering bioelectric controlled down regulation of...